Background: Obesity affects any age, gender and nationality. Pediatric obesity is considered worldwide problem leading to many serious associated health hazards. Untreated obese children will lead to morbid obesity in adulthood. Nonsurgical weight loss programs including exercise, life style modification, diet regimens and weight loss medications rarely have successful results making bariatric surgery an excellent, effective and safe solution for treating obesity and its associated health hazards without affecting the child growth. Patients & methods: This prospective study included 15 morbidly obese patients for whom laparoscopic sleeve gastrectomy (LSG) was done in Cairo and Beni Sueif university hospitals during the period between December 2015 and December 2018. Inclusion criteria were age ≤ 18 years with body mass index (BMI) ≥40 kg/m2 (> 95th percentile for age) or BMI ≥35 kg/m2 and associated with obesity comorbidities. Exclusion criteria included patients with mental retardation, impaired movement, psychological instability, endocrinal disorders causing obesity as hypothyroidism, any contraindication to surgery and those who didn’t previously participate in weight loss program. All patients were followed up for one year. Results: The study included 8 male patients (53.3%) and 7 female patients (46.7%) with a mean age of 13±1.41 years. The mean BMI of our patients is 51.33±10.77 Kg/m2 , the mean operative time is 48.67±5.5 minutes, the mean hospital stay duration of 2.93±1.53 days. In this study 7 patients (46.7%) had co-morbidities. There was significant reduction in the BMI of the patients one year after surgery, it ranged between 22.8 – 55.4 kg/m2 with a mean of 29.5±8.29 kg/m2 . The percentage of the excess body weight loss (% EBWL) ranged between 31.8 and 95% with a mean of 77.37±18.56 one year after surgery with satisfactory results achieved in 13 patients (EBWL 63.5% - 95% after 1 year) .The % EBWL in the remaining 2 cases was 31.8 and 45% one year after surgery. The mean preoperative height was 154.73±19.16cm and the patients gained height by a mean of 160.47±19cm one year after surgery (p<0.001) making LSG safe on children growth. One complication was encountered in one patient (6.66%) in the form of bleeding that was managed successfully by conservative measures. Mortality was not encountered. Conclusion: LSG is a safe reliable solution providing effective sustained body weight loss for morbid obese pediatric patients together with improvement of obesity associated health hazards without adverse effect on children growth. Key Words: Morbid obesity, sleeve gastrectomy, pediatric obesity, bariatric surgery.